
Lisa Rahangdale
Associate Vice Chair of Faculty Development · University of North Carolina Hospitals
Credentials: · · · · ·
History


Present
- 2004–2006
University of California
2000–2004

Research
Human papillomavirus vaccination and cervical cancer risk
Review · BMJ · 2022 · First of 5 authors · Corresponding · 162 citations
Journal of Clinical Virology · 2016 · 52 citations
American Journal of Obstetrics and Gynecology · 2014 · First of 6 authors · Corresponding · 50 citations

18 papers

13 papers
- SM
10 papers

9 papers

9 papers

9 papers

8 papers · 2 as a fellow

8 papers
Grants
- 2026–2031
Enhancing Cervical Cancer Screening Through Integrated Care in Rural North Carolina
National Cancer Institute · R01
PI · $607.4K · Univ of North Carolina Chapel Hill
- 2025–2030
UNC Building Interdisciplinary Research Careers in Women's Health
National Institute of Arthritis and Musculoskeletal and Skin Diseases · K12
Contact PI · $1.9M · Univ of North Carolina Chapel Hill
- 2020–2026
National Cancer Institute · R01
PI · $2.4M · Univ of North Carolina Chapel Hill
Clinical trials
- 2019–2024
Principal investigator · Completed · Early phase 1
National Cancer Institute (NCI)
- 2017–2019
Study of SOR007 Ointment for Cervical Intraepithelial Neoplasia (CIN)
Principal investigator · Withdrawn · Phase 2
DFB Soria, LLC
- 2013
chemQbiosciences:Manual Liquid Based Cytology
Principal investigator · Completed
University of North Carolina, Chapel Hill
- 2010–2014
Female Upper Genital Tract in HIV-infected Women
Principal investigator · Completed
University of North Carolina, Chapel Hill


